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 i  g  h  l i  g  h  t  s
Human  embryonic  stem  cell  derived  neurons  develop  NMDA  and  AMPA  receptors  in  culture.
Enriched  HESC-derived  neurons  develop  functional  glutamate  responses  in  vitro.
MK  801  confers  a protective  effect  on  glutamate-induced  excitotoxic  neuronal  death.
Studies  using  human  pluripotent  stem  cells  may  aid  the discovery  of  novel  therapeutic  targets.
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a  b  s  t  r  a  c t
Thanks  to the  development  of  efﬁcient  differentiation  strategies,  human  pluripotent  stem  cells  (HPSC)
offer  the opportunity  for  modelling  neuronal  injury  and  dysfunction  in  human  neurons  in vitro.  Critically,
the  effective  use  of  HPSC-derived  neural  cells  in  disease-modelling  and  potentially  cell replacement
therapies  hinges  on  an  understanding  of  the  biology  of these  cells,  speciﬁcally  their  development,  sub-
type  speciﬁcation  and  responses  to  neurotoxic  signalling  mediators.  Here,  we  generated  neurons  from
human  embryonic  stem  cells  and  characterised  the  development  of  vulnerability  to  glutamate  excito-K 801
xcitotoxicity
lutamate
isease-modelling
toxicity,  a key  contributor  to neuronal  injury  in several  acute  and  chronic  neurodegenerative  disorders.
Over  two  months  of  differentiation  we  observed  a gradual  increase  in responsiveness  of neurons  to
glutamate-induced  Ca2+ inﬂux,  attributable  to  NMDA  receptor  activity.  This  increase  was  concomitant
with  an  increase  in  expression  of mRNA  encoding  NMDA  and  AMPA  receptor  subunits.  Differentiated
neurons  were  vulnerable  to  glutamate  excitotoxicity  in a  dose-dependent  manner,  which  was  reduced
by  NMDA  receptor  antagonists.. Introduction
Glutamate excitotoxicity, both acute and chronic, has been
mplicated widely in the pathogenesis of a range of neurologi-
al diseases, including Alzheimer’s disease, Huntington’s disease
nd traumatic brain injury [25,28]. Knowledge of the role and
echanisms of glutamate excitotoxicity can potentially enhance
ur understanding of key downstream signalling processes that
Abbreviations: aCSF, artiﬁcial cerebrospinal ﬂuid; AMPA, 2-amino-3-(5-methyl-
-oxo-1,2-oxazol-4-yl)propanoic acid; AMPAR, 2-amino-3-(5-methyl-3-oxo-1,2-
xazol-4-yl)propanoic acid receptor; D-APV, aminophosphonopentanoic acid;
ESC, human embryonic stem cell; HPSC, human pluripotent stem cell; iPSC,
nduced  pluripotent stem cell; NPC, neural precursor cell; NMDA, N-methyl-d-
spartic  acid; NMDAR, N-methyl-d-aspartic acid receptor.
∗ Corresponding author at: Department of Neurological Surgery, Oregon Health
nd  Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
E-mail address: kg244@cantab.net (K. Gupta).
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mediate neuronal death and identify novel therapeutic targets. A
major cause of glutamate excitotoxicity is activation of the NMDA
subtype of glutamate receptor (NMDAR), which mediates Ca2+-
dependent cell death [26]. Most NMDARs contain two  obligate
GluN1 subunits plus two  GluN2 subunits [11], of which there
are four subtypes, GluN2A-D, with GluN2A and GluN2B predom-
inant in the forebrain [30,40]. While physiological patterns of
synaptic NMDAR activity have the potential to be neuroprotective
[15,19,39], excessive or inappropriate activity is harmful. The work
of many laboratories has advanced our understanding of how loss of
glutamate homeostasis, ionic imbalance and inappropriate NMDAR
activity can contribute to degenerative disorders [8,16,22,25,27].
Antagonism of pathological glutamate-signalling in rodent
models of neurological diseases has yielded promising results
Open access under CC BY license.[6,10], though unsuccessful clinical trials highlight the need for
further studies [1,31]. Currently, excitotoxic neuronal cell death
has primarily been characterised in rodent systems. Advances
in human pluripotent stem cell (HPSC) technology permit the
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eneration of enriched neurons of differing positional identities as
ell as astrocytes from human embryonic stem cells (HESC) and
llow investigation of cell injury and rescue paradigms in a human
n vitro system [12,13,23,24,35,38].  In light of the inter-species dif-
erences between rodent and human [34], studies utilising human
n vitro systems may  prove informative in interpreting the rel-
vance of ﬁndings in rodent studies to the human pathological
ondition [3,13,18].
Here,  we describe the functional maturation of HESC-derived
eurons and the development of glutamate-responsiveness, in
rder to study neuronal responses to pathologically relevant gluta-
ate concentrations [5].
. Materials and methods
HESC  Culture and neuralisation: The human embryonic stem
ell (HESC) line H9 (Harvard University, Cambridge, MA)  was cul-
ured and passaged regularly on a feeder layer of irradiated mouse
mbryonic ﬁbroblasts, and neuralised by established protocols [21].
ESC-derived neurons were generated by methodologies described
y Koch et al. [23]. Enriched HESC-derived neural precursor cells
NPCs) were propagated in Advanced DMEM/F12, 1% Glutamax,
% N2 supplement 1% penicillin-streptomycin, 0.1% B27 supple-
ent, 10 ng/ml FGF and 10 ng/ml EGF. Coverslips were coated with
atrigel (BD Biosciences) for 1hr, diluted 1:30 in DMEM.  NPCs were
lated in NPC propagation medium without mitogens for 24 h and
witched to Neurobasal-A, supplemented with 1% non-essential
mino acids, 1% N2 supplement, 1% penicillin-streptomycin, 0.5%
lutamax, 10 ng/ml BDNF, 10 M forskolin, 0.1 M retinoic acid
or neuronal differentiation. 50 M DAPT [4] was included in the
rst medium change. These HESC-neuronal cultures are consistent
ith those described in Gupta et al. [13] in cellular composi-
ion; 95% were neurons and the remainder astrocytes, conﬁrmed
y TuJ1 and GFAP immunostaining. Differentiation duration was
etermined from the day of application of neuronal differentia-
ion medium to NPCs. The day before experiments, HESC-derived
eurons were removed from their trophic differentiation medium
nto a trophically deprived, glutamate-free “minimal medium” [13],
hich comprises 90% Salt-Glucose-Glycine (SGG) medium [2] and
0% MEM  (Minimal Essential Medium, Invitrogen).
Calcium-imaging: The day before imaging, HESC-derived neu-
ons were removed from their trophic differentiation medium
nto a trophically deprived, glutamate-free minimum medium as
escribed above. HESC-neurons, identiﬁed by morphology and
onﬁrmed by TuJ1 immunostaining, were imaged at various time-
oints in artiﬁcial cerebrospinal ﬂuid (aCSF) [39] on a 37 ◦C-heated
tage. Cells were loaded with 11 M Fluo-3 for 30 min  and washed
n aCSF. Coverslips were mounted in a perfusion chamber. Fluo-
 ﬂuorescence images (excitation 488 nm/emission 520 nm)  were
aken at baseline and during saturating glutamate (200 M)  and
MDA (150 M)  stimulation. Glycine (100 M)  was  applied as a
o-agonist. D-APV (50 M)  was used as an NMDAR antagonist.
or calibration, ionomycin was used to saturate the Fluo-3 sig-
al (50 M),  followed by MnCl2 (10 mM)  to quench. The quenched
luo-3 signal corresponds to ∼100 nM Ca++. The Kd of Fluo-3 was
aken as 315 nM and free Ca++ concentration was calculated by
he formula Ca++ = Kd (F − Fmin)/(Fmax – F), where F is ﬂuorescence.
mages  were taken every second for the duration of each experi-
ent (∼10 min) [17].
Gene expression analysis: Total RNA was isolated via the
bsolutely RNA miniprep kit, as described [13]. cDNA synthesis per-
ormed via the AfﬁnityScript cDNA (Stratagene) synthesis kit using
ligo-dT and random hexamer primers, and qRT-PCR performed
sing Brilliant SYBR Green master mix  (Stratagene), following
he manufacturer’s instructions. Forward and reverse primertters 543 (2013) 95– 100
sequences:  GRIN1 AGGAACCCCTCGGACAAGTT, CCGCACTCTCG-
TAGTTGTG; GRIN2A TGGACGTGAACGTGGTAGC, CCCCCATGAAT-
GCCCAAGAT; GRIN2B TTCCGTAATGCTCAACATCATGG, TGCTGCG-
GATCTTGTTTACAAA; GRIN2 C GAGTGGTCAAATTCTCCTACGAC,
TGTAGTACACCTCCCCAATCAT; GRIN2D CTGGCCTCACTGGATCTGG,
GGAAGGAAACCATAATCACGCA; GRIA1 GGTCTGCCCTGA-
GAAATCCAG, CTCGCCCTTGTCGTACCAC; GRIA2 AGTTTTC-
CACTTCGGAGTTCAG, CCAAATTGTCGATGTGGGGTG; GRIA3
TCCGGGCGGTCTTCTTTTTAG, TGGGGAATCCTCCGTGAGAAT; GRIA4
GCCATTGTCCCTGATGGAAAA, GAGGGGCAATAGCAATCTCTG;
GAPDH  AGGCTGGGGCTCATTTG, CAGTTGGTGGTGCAGGAG.
Electrophysiology: Whole-cell NMDA-evoked currents were
recorded using an Axopatch 200B ampliﬁer (Molecular Devices)
using patch-pipettes made from thick-walled borosilicate glass
with a tip resistance of 4–8 M that were ﬁlled with an ‘inter-
nal’ solution that contained (in mM):  K-gluconate 141, NaCl 2.5,
HEPES 10, EGTA 11; pH 7.3 with KOH. Experiments were con-
ducted at room temperature (18–21 ◦C) in an ‘external’ solution
containing (in mM):  NaCl 150, KCl 2.8, HEPES 10, CaCl2 4, glucose
10, pH to 7.3 with NaOH. Picrotoxin (50 M),  strychnine (20 M)
and tetrodotoxin (300 nM)  were also included. NMDAR-mediated
currents were induced by the addition of saturating concentrations
of NMDA (100 M)  and the co-agonist glycine (100 M)  to the
external solution. Access resistances were monitored and recor-
dings where this changed by >20% were discarded. Currents were
ﬁltered at 2 kHz and digitised online at 5 kHz via a BNC-2090A/PCI-
6251 DAQ board interface (National Instruments, Austin, TX, USA).
Neuronal injury and Cell viability assays: The day before
application of the excitotoxic insult, HESC-derived neurons were
removed from their trophic differentiation medium into a troph-
ically deprived, glutamate-free minimal medium. Neurons were
treated with glutamate with and without MK801 (10 M)  [29].
24 h after excitotoxic challenge, cell viability was quantiﬁed using
CellTiter-Glo Luminescent Cell Viability Assay (Promega), following
manufacturer’s instructions. Neuronal injury experiments using
high-dose NMDA (150 M)  [29], were performed in magnesium-
free SGG medium [2]; cell viability was quantiﬁed after 24 h by the
same protocol.
Data  analysis: All experiments were performed with at least 3
biological repeats; within each, 3 technical repeats were gener-
ated. qPCR data were normalised to GAPDH. Data are presented
as mean ± standard error of the mean; statistical analyses were
performed in Microsoft Excel and GraphPad Prism 5 (GraphPad
Software, Inc., San Diego) by univariate and two-way ANOVA with
Newman-Keuls post-test and two-tailed Students’ t-test. P < 0.05
was considered statistically signiﬁcant.
3. Results
3.1. Temporal proﬁle of in vitro acquisition of HESC-derived
neuronal glutamate responses
In order to study excitotoxic responses in a human platform,
enriched cultures of HESC-derived neurons were examined for
functional glutamate-mediated responses. Neurons were stimu-
lated with saturating glutamate (200 M)  and functional glutamate
receptor activity was  determined by calcium-imaging over increas-
ing duration in culture. While initially unresponsive to glutamate
(including doses of 1 mM glutamate: data not shown), HESC-
derived neurons developed calcium currents in response to
bath-extracellular glutamate application with increasing dura-
tion in culture. 2-week old HESC-derived neurons demonstrated
no signiﬁcant calcium inﬂux, while later time points demon-
strated signiﬁcant calcium inﬂux with glutamate treatment, with
peak calcium currents increasing over time to maximal at 6 and
K. Gupta et al. / Neuroscience Letters 543 (2013) 95– 100 97
Fig. 1. HESC-derived neurons were differentiated from 2 to 8-weeks and stimulated with 200 M glutamate. (a) Development of glutamate-provoked calcium currents was
dependent on culture duration. (b) The proportion of glutamate-sensitive neurons in the cultures also increased over time. Peak calcium current and maximal proportion of
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Glutamate-responsive neurons were observed by 6-weeks in culture (*p < 0.001). H
 and 8-weeks in culture, by qRT-PCR. Signiﬁcant increases in (c) NMDA and (d) AM
-weeks  suggested that GRIN1 and GRIN2B, and GRIA1 and GRIA2 were the most hig
-weeks duration in culture (p < 0.001, Fig. 1a). The proportion
f HESC-derived neurons that exhibited glutamate-evoked cal-
ium currents similarly showed a time-dependent increase from
3 ± 3% at 2-weeks and 15 ± 1% at 3-weeks, 54.4 ± 5% at 4-weeks,
o 77.7 ± 4% and 73.0 ± 3% at 6 and 8-weeks respectively (p < 0.001,
ig. 1b). Thus, HESC-derived neurons acquired functional glutamate
esponsiveness over time in culture.
.2. Development of functional glutamate responses coincides
ith  expression of NMDA and AMPA receptor subunits
In order to determine if the temporal emergence of glutamate-
esponsiveness was due to increasing expression of glutamate
eceptors, we quantiﬁed the expression of NMDAR and AMPAR
ubunits in glutamate-unresponsive neurons at 2-weeks and in
lutamate-responsive neurons at 6 and 8-weeks by qRT-PCR.
The  NMDAR is a heterotetramer of two  obligatory GluN1
ubunits encoded by GRIN1, and two variable GluN2 subunits
ncoded by GRIN2 genes. Expression of NMDAR subunit GRIN1
ncreased from 2 to 6 and 8-weeks in culture by 1.9 ± 0.12-fold and
.8 ± 0.25-fold respectively (p < 0.01). GRIN2A expression decreased
t 6 and 8-weeks, to 0.6 ± 0.04-fold and 0.6 ± 0.03-fold respec-
ively (p < 0.01). GRIN2B expression increased from 2-weeks to
.4 ± 0.04-fold and 1.7 ± 0.01-fold and 6 and 8-weeks respectively
p < 0.05). There was no signiﬁcant change in GRIN2C expression at
 and 8-weeks (0.5 ± 0.13 and 1.5 ± 0.2-fold respectively). GRIN2D
xpression increased to 1.3 ± 0.07 and 1.5 ± 0.1-fold at 6 and 8-
eeks respectively (p < 0.05, Fig. 1c). These data demonstrated
n increase in expression of NMDAR subunits GRIN1, GRIN2B and
RIN2D in HESC-derived neurons over 8-weeks in culture, but noterived neurons were investigated for NMDAR and AMPAR subunit expression at 2,
bunit expression were observed (*p < 0.01). Comparison with baseline ct values at
pressed receptor subunits at 6 and 8-weeks in culture.
GRIN2A. Analysis of ct values suggested that NMDAR subunits 1 and
2B were the most highly expressed.
AMPAR subunit quantiﬁcation showed that GRIA1 expression
increased signiﬁcantly from 2 to 6 and 8-weeks, by 2.0 ± 0.08
and 3.0 ± 0.3-fold respectively (p < 0.01). GRIA2 similarly increased
with duration in culture, to 1.8 ± 0.07-fold and 2.5 ± 0.04-fold after
6 and 8-weeks respectively (p < 0.01). GRIA3 and GRIA4 showed
no signiﬁcant change in expression at 6-weeks (1.0 ± 0.04-fold
and 1.0 ± 0.03-fold respectively) and a signiﬁcant, although mod-
est, increase in expression at 8-weeks (1.23 ± 0.027-fold and
1.22 ± 0.033-fold respectively, p < 0.05, Fig. 1d). These data demon-
strated an increase in AMPAR expression of HESC-derived neurons
over time in culture. Analysis of ct values suggested that AMPAR
subunits 1 and 2 were the most highly expressed.
The NMDAR and AMPAR proﬁles were dynamic over the course
of the period studied, with increasing expression of AMPAR and
NMDAR subunits GluN1 and GluN2B coinciding with the develop-
ment of functional glutamate responses in vitro. Given that during
development rodent neurons undergo a transition from GluN2B
subunit-containing NMDARs to GluN2A predominance [41], the
NMDAR subunit proﬁle in HESC-derived neurons may  change fur-
ther over time.
3.3.  HESC-derived neurons express functional NMDA receptors
In  order to determine whether the glutamate-induced cal-
cium inﬂux was  dependent on the expression of functional
NMDARs, receptor-mediated calcium currents were quantiﬁed
in 8-week HESC-derived neuronal cultures using NMDA-glycine
co-treatment. Data demonstrated that HESC-derived neurons
exhibited calcium currents upon NMDA application, which were
98 K.  Gupta et al. / Neuroscience Letters 543 (2013) 95– 100
Fig. 2. HESC-derived neurons were cultured for 6-weeks and stimulated with NMDA. (a) 100 M NMDA elicited intracellular calcium currents, which were blocked by
concurrent 50 M D-APV administration (NMDAR antagonist) (*p < 0.05). (b) Neuronal responses to NMDA were conﬁrmed by electrophysiology, demonstrating inward
currents with 50 M NMDA stimulation. (c) 7-week-old HESC-derived neurons were challenged with increasing glutamate concentrations in minimal medium, and cell
viability  assessed at 24 h after challenge. HESC-derived neurons were sensitive to glutamate-induced excitotoxic cell death, demonstrating 58 ± 6% cell death with 20 M
glutamate. (d) MK801, a non-speciﬁc NMDAR blocker, was  added to HESC-derived neurons simultaneously with 20 M glutamate challenge. Excitotoxic cell death was
q duced
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(uantiﬁed after 24 h. MK801 co-administration signiﬁcantly reduced glutamate-in
50  M NMDA and neuronal death quantiﬁed after 24 h. Both conditions described 
ontrol medium (*p < 0.001).
locked with application of D-APV, a selective NMDAR inhibitor
p < 0.05, Fig. 2a). NMDAR currents were further conﬁrmed by
atch-clamp electrophysiology (Fig. 2b).
.4. HESC-derived neurons demonstrate excitotoxic cell death at
athophysiological glutamate concentrations, and are rescued by
K801-mediated NMDA receptor blockade
The susceptibility of 7-week-old HESC-derived neurons to
lutamate-induced cell death was determined over a range of
oncentrations. With increasing glutamate concentrations, increas-
ng cell death was observed: at 20 M,  58% ± 5.98%; at 40 M,
2 ± 6.45%; and at 80 M,  71 ± 6.64% cell death was noted (Fig. 2c).
00% cell death was induced with application of 50 M stau-
osporine. As 20 M glutamate is in the pathophysiological range
or extracellular glutamate concentration in human traumatic brain
njury patients [5], MK801 was assayed against this concentration.
In vitro studies on rodent neurons demonstrated the efﬁcacy
f NMDAR antagonists in preventing excitotoxic neuronal death
6]. To investigate the role of NMDARs in glutamate excitotoxic-
ty in our system, enriched HESC-derived neuronal cultures were
xposed to 20 M glutamate in the presence and absence of MK801
10 M)  for 24 h. MK801 conferred a signiﬁcant neuroprotective excitotoxic cell death (*p < 0.05). (e) HESC-derived neurons were challenged with
erformed in magnesium-free SGG medium, and compared to trophically-deprived
effect against glutamate-induced excitotoxic injury (33.2 ± 8.4%
cell death compared to control: 57.5 ± 3.4%; p < 0.05, Fig. 2d).
When challenged with 150 M NMDA, neuronal death was also
observed (27.7 ± 3.6%; p < 0.001, Fig. 2e), however at lower lev-
els than those induced by glutamate. Further work is required to
elucidate the downstream signalling pathways that mediate glu-
tamate and NMDA-induced excitotoxic neuronal dysfunction and
death. Establishment of a robust platform for functional glutamate
transmission and excitotoxicity in human neurons permits exam-
ination of these downstream pathways and could potentially aid
the discovery of novel therapeutic targets.
4. Discussion
Pathological stimulation of NMDAR by glutamate has been
implicated in excitotoxic injury and channel blockers have been
trialled in human conditions to poor effect [20], suggesting that
our understanding of human NMDAR-signalling is incomplete and
reliable human-based experimental models could be informative,
alongside animal studies. However, the development of glutamate-
dependent currents was  previously uncharacterised in enriched
HESC-derived neurons in vitro.
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In these studies, we demonstrate that HESC-derived neurons,
ithin the context of the current experimental platform, acquired
aturation-dependent glutamate-responsiveness over time in cul-
ure; knowledge of these characteristics is critical for the use
f HESC-neural derivatives in models of neurological injury. By
RNA expression studies, there were large increases in transcrip-
ion of GRIN1 encoding the constitutive NMDAR1 subunit, GRIA1
ncoding the AMPAR1 subunit, and modest increases in further
MDAR and AMPAR subunit genes. These modest transcriptional
ncreases translated to the expression of functional and properly
ssembled NMDARs as determined by functional studies herein,
tilising NMDA as a speciﬁc agonist and the selective inhibitor D-
PV. Furthermore, quantitative studies of current amplitude and
he proportion of glutamate-responsive cells demonstrated grad-
al increase of receptor function over duration in culture, thus
uggesting neuronal-intrinsic modulation of glutamate-receptor
xpression and functional downstream-signalling over time. Direct
onﬁrmation of NMDAR and AMPAR subunit proﬁles could be elu-
idated further by electrophysiological studies with appropriate
ubunit-speciﬁc inhibitors. The mRNA expression data also sug-
ested that NMDAR subunit expression was dynamic over the
n vitro time course, with GluN2B predominance. It remained to be
een whether the subunit proﬁle would develop over time to reca-
itulate the conversion from GluN2B to GluN2A predominance in
xperimental mammalian systems [41].
In this study, glutamate was investigated as a physiologically
elevant stressor due to its direct pathophysiological role in dis-
ase states. Dose-survival curves demonstrated that HESC-derived
eurons underwent glutamate-induced cell death over the range
f concentrations seen in human brain injury patients in vivo [5],
nd could be rescued with MK801 co-administration. Similar con-
entrations of glutamate and MK801 have also been demonstrated
o mediate excitotoxic cell death and protection in rodent in vitro
tudies [7,37], and in human neurons derived from the human NT2
eratocarcinoma cell-line [14,32].
Interestingly, MK801 did not completely block glutamate-
ediated neuronal death and, furthermore, NMDA alone induced a
ower level of neuronal death than that mediated by glutamate.
hese ﬁndings suggest other mechanisms of glutamate-induced
euronal death in addition to NMDAR-mediated excitotoxic-
ty. Glutamate in high concentrations has been demonstrated
o cause oxidative-stress mediated neuronal death by compet-
tively inhibiting cystine uptake via the Xct cystine/glutamate
ntiporter  and impairing glutathione production [33,37]. While
he concentrations used to experimentally induce glutamate-
nduced oxidative cell death are typically in the millimolar range
36], excitotoxic neuronal death at lower glutamate concentra-
ions, mediated by NMDAR activation, has been shown to result
n further glutamate release and accumulation in medium to
igher concentrations capable of mediating oxidative neuronal
eath [37]. Calcium-permeable AMPARs, lacking the GluR2 subunit
hat prevents calcium permeability, have also been demonstrated
o mediate hippocampal neuronal death in rodent slice cul-
ures. Oxygen-glucose-deprivation increases synaptic-trafﬁcking
f GluR2-lacking AMPARs in CA1 hippocampal neurons, caus-
ng AMPAR mediated excitotoxic cell death [9]. The pre-exposure
f HESC-neurons to trophically-deprived medium in the current
xperimental model may  have affected the trafﬁcking of AMPAR
nd partially accounted for the MK801-insensitive excitotoxic neu-
onal death observed..  Conclusions
Human pluripotent stem cell technology, including HESCs and
PSCs, has tremendous potential for modelling neurological disease
[
[tters 543 (2013) 95– 100 99
processes.  Technological advances have allowed the generation of
enriched human neurons and glia under deﬁned conditions, per-
mitting study of human neural cells in vitro [13,24,35]. Here, we
characterised a population of enriched HESC-derived neurons in
terms of development of glutamatergic responses and investigated
their utility in modelling glutamate-induced neuronal injury. We
established that after 2 months in culture, HESC-derived neurons
underwent excitotoxic cell death at concentrations of glutamate
found in the brains of human patients suffering acquired brain
injury, and thus have the potential to recapitulate aspects of human
pathophysiology. Furthermore, insights from the development and
reﬁnement of HESC-based platforms for in vitro modelling of neu-
ronal injury and rescue will be critical for the development of other
HPSC-based complementary systems, including iPSCs.
Conﬂict of interest
The  authors declare no conﬂicts of interest and have approved
the ﬁnal article.
Acknowledgements
K.G.  performed the research; K.G., G.E.H., S.C. prepared the
manuscript. The authors thank Sean McKay for assistance with
electrophysiological studies. K.G. is funded by a Wellcome Trust
Clinical Training Fellowship. G.E.H. and S.C. laboratories are funded
by the Medical Research Council, the Biotechnology and Biological
Sciences Research Council, and the Wellcome Trust.
References
[1] G.W. Albers, W.M.  Clark, R.P. Atkinson, K. Madden, J.L. Data, M.J. Whitehouse,
Dose escalation study of the NMDA glycine-site antagonist licostinel in acute
ischemic stroke, Stroke 30 (1999) 508–513.
[2]  H. Bading, D.D. Ginty, M.E. Greenberg, Regulation of gene expression in hip-
pocampal neurons by distinct calcium signaling pathways, Science 260 (1993)
181–186.
[3]  K.F. Bell, B. Al-Mubarak, J.H. Fowler, P.S. Baxter, K. Gupta, T. Tsujita, S. Chowdhry,
R. Patani, S. Chandran, K. Horsburgh, J.D. Hayes, G.E. Hardingham, Mild oxida-
tive stress activates Nrf2 in astrocytes, which contributes to neuroprotective
ischemic preconditioning, Proc. Natl. Acad. Sci. U.S.A. 108 (2011) E1-2, author
reply E3-4.
[4]  L. Borghese, D. Dolezalova, T. Opitz, S. Haupt, A. Leinhaas, B. Steinfarz, P. Koch,
F. Edenhofer, A. Hampl, O. Brustle, Inhibition of notch signaling in human
embryonic stem cell-derived neural stem cells delays G1/S phase transition and
accelerates neuronal differentiation in vitro and in vivo, Stem Cells 28 (2010)
955–964.
[5]  R. Bullock, A. Zauner, J.J. Woodward, J. Myseros, S.C. Choi, J.D. Ward, A. Mar-
marou, H.F. Young, Factors affecting excitatory amino acid release following
severe human head injury, J. Neurosurg. 89 (1998) 507–518.
[6] D.W. Choi, Calcium-mediated neurotoxicity: relationship to speciﬁc channel
types and role in ischemic damage, Trends Neurosci. 11 (1988) 465–469.
[7] D.W. Choi, M.  Maulucci-Gedde, A.R. Kriegstein, Glutamate neurotoxicity in cor-
tical cell culture, J. Neurosci. 7 (1987) 357–368.
[8]  T.M. Dawson, J. Zhang, V.L. Dawson, S.H. Snyder, Nitric oxide: cellular regulation
and neuronal injury, Progr. Brain Res. 103 (1994) 365–369.
[9] R.M. Dixon, J.R. Mellor, J.G. Hanley, PICK1-mediated glutamate receptor sub-
unit 2 (GluR2) trafﬁcking contributes to cell death in oxygen/glucose-deprived
hippocampal  neurons, J. Biol. Chem. 284 (2009) 14230–14235.
10] E. Esposito, I. Paterniti, E. Mazzon, T. Genovese, M.  Galuppo, R. Meli, P. Bramanti,
S. Cuzzocrea, MK801 attenuates secondary injury in a mouse experimental
compression model of spinal cord trauma, BMC  Neurosci. 12 (2011) 31.
11]  H. Furukawa, S.K. Singh, R. Mancusso, E. Gouaux, Subunit arrangement and
function in NMDA receptors, Nature 438 (2005) 185–192.
12] K. Gupta, S. Chandran, G.E. Hardingham, Human stem cell-derived astrocytes
and their application to studying Nrf2-mediated neuroprotective pathways and
therapeutics in neurodegeneration, Br. J. Clin. Pharmacol. (2012).
13] K. Gupta, R. Patani, P. Baxter, A. Serio, D. Story, T. Tsujita, J.D. Hayes, R.A.
Pedersen, G.E. Hardingham, S. Chandran, Human embryonic stem cell derived
astrocytes mediate non-cell-autonomous neuroprotection through endoge-
nous and drug-induced mechanisms, Cell Death Differ. 19 (2012) 779–787.14] E. Hanko, T.W. Hansen, R. Almaas, R. Paulsen, T. Rootwelt, Synergistic protection
of a general caspase inhibitor and MK-801 in bilirubin-induced cell death in
human NT2-N neurons, Pediatr. Res. 59 (2006) 72–77.
15]  G.E. Hardingham, Pro-survival signalling from the NMDA receptor, Biochem.
Soc. Trans. 34 (2006) 936–938.
1 nce Le
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[00 K.  Gupta et al. / Neuroscie
16]  G.E. Hardingham, H. Bading, Synaptic versus extrasynaptic NMDA receptor
signalling: implications for neurodegenerative disorders, Nat. Rev. Neurosci.
11 (2010) 682–696.
17] G.E. Hardingham, S. Chawla, C.M. Johnson, H. Bading, Distinct functions of
nuclear and cytoplasmic calcium in the control of gene expression, Nature 385
(1997) 260–265.
18] G.E. Hardingham, R. Patani, P. Baxter, D.J. Wyllie, S. Chandran, Human embry-
onic stem cell-derived neurons as a tool for studying neuroprotection and
neurodegeneration, Mol. Neurobiol. 42 (2010) 97–102.
19] C. Ikonomidou, F. Bosch, M.  Miksa, P. Bittigau, J. Vockler, K. Dikranian, T.I.
Tenkova, V. Stefovska, L. Turski, J.W. Olney, Blockade of NMDA receptors
and apoptotic neurodegeneration in the developing brain, Science 283 (1999)
70–74.
20]  C. Ikonomidou, L. Turski, Why  did NMDA receptor antagonists fail clinical trials
for stroke and traumatic brain injury? Lancet Neurol. 1 (2002) 383–386.
21] A.J. Joannides, C. Fiore-Heriche, A.A. Battersby, P. Athauda-Arachchi, I.A.
Bouhon, L. Williams, K. Westmore, P.J. Kemp, A. Compston, N.D. Allen, S. Chan-
dran, A scaleable and deﬁned system for generating neural stem cells from
human embryonic stem cells, Stem Cells 25 (2007) 731–737.
22] L.V. Kalia, S.K. Kalia, M.W.  Salter, NMDA receptors in clinical neurology: excit-
atory times ahead, Lancet Neurol. 7 (2008) 742–755.
23]  P. Koch, T. Opitz, J. Steinbeck, J. Ladewig, O. Brustle, A rosette-type, self-
renewing human ES cell-derived neural stem cell with potential for in vitro
instruction and synaptic integration, Proc. Natl. Acad. Sci. U.S.A. 106 (2009)
3225–3230.
24]  R. Krencik, J.P. Weick, Y. Liu, Z.J. Zhang, S.C. Zhang, Speciﬁcation of trans-
plantable astroglial subtypes from human pluripotent stem cells, Nat.
Biotechnol. 29 (2011) 528–534.
25] A. Lau, M.  Tymianski, Glutamate receptors, neurotoxicity and neurodegenera-
tion, Pﬂugers Arch. 460 (2010) 525–542.
26]  S.A. Lipton, Paradigm shift in neuroprotection by NMDA receptor blockade:
memantine and beyond, Nat. Rev. 5 (2006) 160–170.
27]  S.A. Lipton, P.A. Rosenberg, Excitatory amino acids as a ﬁnal common pathway
for neurologic disorders, N. Engl. J. Med. 330 (1994) 613–621.
28] N.J. Maragakis, J.D. Rothstein, Glutamate transporters in neurologic disease,
Arch. Neurol. 58 (2001) 365–370.
29] M.A. Martel, T.J. Ryan, K.F. Bell, J.H. Fowler, A. McMahon, B. Al-Mubarak, N.H.
Komiyama, K. Horsburgh, P.C. Kind, S.G. Grant, D.J. Wyllie, G.E. Hardingham, The
[tters 543 (2013) 95– 100
subtype of GluN2 C-terminal domain determines the response to excitotoxic
insults, Neuron 74 (2012) 543–556.
30] H. Monyer, N. Burnashev, D.J. Laurie, B. Sakmann, P.H. Seeburg, Developmental
and regional expression in the rat brain and functional properties of four NMDA
receptors, Neuron 12 (1994) 529–540.
31]  G.F. Morris, R. Bullock, S.B. Marshall, A. Marmarou, A. Maas, L.F. Marshall, Failure
of the competitive N-methyl-d-aspartate antagonist Selfotel (CGS 19755) in
the treatment of severe head injury: results of two  phase III clinical trials. The
Selfotel Investigators, J. Neurosurg. 91 (1999) 737–743.
32] M.  Munir, L. Lu, P. McGonigle, Excitotoxic cell death and delayed rescue in
human neurons derived from NT2 cells, J. Neurosci. 15 (1995) 7847–7860.
33] T.H. Murphy, M.  Miyamoto, A. Sastre, R.L. Schnaar, J.T. Coyle, Glutamate tox-
icity in a neuronal cell line involves inhibition of cystine transport leading to
oxidative stress, Neuron 2 (1989) 1547–1558.
34]  N.A. Oberheim, T. Takano, X. Han, W.  He, J.H. Lin, F. Wang, Q. Xu, J.D. Wyatt,
W. Pilcher, J.G. Ojemann, B.R. Ransom, S.A. Goldman, M. Nedergaard, Uniquely
hominid features of adult human astrocytes, J. Neurosci. 29 (2009) 3276–3287.
35]  R. Patani, D.A. Compston, C. Puddifoot, D.J. Wyllie, G.E. Hardingham, N.D. Allen,
S. Chandran, Activin/Nodal inhibition alone accelerates highly efﬁcient neural
conversion from human embryonic stem cells and imposes a caudal positional
identity, PLoS One 4 (2009) e7327.
36] R.R. Ratan, T.H. Murphy, J.M. Baraban, Oxidative stress induces apoptosis in
embryonic cortical neurons, J. Neurochem. 62 (1994) 376–379.
37] D. Schubert, D. Piasecki, Oxidative glutamate toxicity can be a component of
the excitotoxicity cascade, J. Neurosci. 21 (2001) 7455–7462.
38] S. Shin, S. Dalton, S.L. Stice, Human motor neuron differentiation from human
embryonic stem cells, Stem Cells Dev. 14 (2005) 266–269.
39] F.X. Soriano, S. Papadia, F. Hofmann, N.R. Hardingham, H. Bading, G.E. Harding-
ham, Preconditioning doses of NMDA promote neuroprotection by enhancing
neuronal excitability, J. Neurosci. 26 (2006) 4509–4518.
40] S.F. Traynelis, L.P. Wollmuth, C.J. McBain, F.S. Menniti, K.M. Vance, K.K.
Ogden, K.B. Hansen, H. Yuan, S.J. Myers, R. Dingledine, Glutamate receptor
ion channels: structure, regulation, and function, Pharmacol. Rev. 62 (2010)
405–496.
41]  A. Wenzel, J.M. Fritschy, H. Mohler, D. Benke, NMDA receptor heterogene-
ity during postnatal development of the rat brain: differential expression
of the NR2A, NR2B, and NR2C subunit proteins, J. Neurochem. 68 (1997)
469–478.
